Walgreens Boots Alliance, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Walgreens Boots Alliance, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2014 to Q2 2024.
  • Walgreens Boots Alliance, Inc. Income Tax Expense (Benefit) for the quarter ending May 31, 2024 was $20M.
  • Walgreens Boots Alliance, Inc. Income Tax Expense (Benefit) for the twelve months ending May 31, 2024 was -$987M, a 49.2% increase year-over-year.
  • Walgreens Boots Alliance, Inc. annual Income Tax Expense (Benefit) for 2023 was -$1.86B, a 6093% decline from 2022.
  • Walgreens Boots Alliance, Inc. annual Income Tax Expense (Benefit) for 2022 was -$30M, a 104% decline from 2021.
  • Walgreens Boots Alliance, Inc. annual Income Tax Expense (Benefit) for 2021 was $667M, a 96.8% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$987M $20M +$350M Mar 1, 2024 May 31, 2024 10-Q 2024-06-27
Q1 2024 -$1.34B -$782M -$852M -1217% Dec 1, 2023 Feb 29, 2024 10-Q 2024-03-28
Q4 2023 -$485M -$74M +$1.37B +94.9% Sep 1, 2023 Nov 30, 2023 10-Q 2024-01-04
Q3 2023 -$1.86B -$151M +$84M +35.7% Jun 1, 2023 Aug 31, 2023 10-K 2023-10-12
Q2 2023 -$1.94B -$330M -$88M -36.4% Mar 1, 2023 May 31, 2023 10-Q 2024-06-27
Q1 2023 -$1.85B $70M -$102M -59.3% Dec 1, 2022 Feb 28, 2023 10-Q 2024-03-28
Q4 2022 -$1.75B -$1.45B -$1.72B -626% Sep 1, 2022 Nov 30, 2022 10-Q 2024-01-04
Q3 2022 -$30M -$235M -$821M -140% Jun 1, 2022 Aug 31, 2022 10-K 2023-10-12
Q2 2022 $791M -$242M -$488M -198% Mar 1, 2022 May 31, 2022 10-Q 2023-06-27
Q1 2022 $1.28B $172M +$130M +310% Dec 1, 2021 Feb 28, 2022 10-Q 2023-03-28
Q4 2021 $1.15B $275M +$482M Sep 1, 2021 Nov 30, 2021 10-Q 2023-01-05
Q3 2021 $667M $586M +$385M +192% Jun 1, 2021 Aug 31, 2021 10-K 2023-10-12
Q2 2021 $282M $246M +$289M Mar 1, 2021 May 31, 2021 10-Q 2022-06-30
Q1 2021 -$7M $42M -$107M -71.8% Dec 1, 2020 Feb 28, 2021 10-Q 2022-03-31
Q4 2020 $100M -$207M -$239M -747% Sep 1, 2020 Nov 30, 2020 10-Q 2022-01-06
Q3 2020 $339M $201M +$186M +1240% Jun 1, 2020 Aug 31, 2020 10-K 2022-10-13
Q2 2020 $153M -$43M -$199M -128% Mar 1, 2020 May 31, 2020 10-Q 2021-07-01
Q1 2020 $352M $149M -$77M -34.1% Dec 1, 2019 Feb 29, 2020 10-Q 2021-03-31
Q4 2019 $429M $32M -$148M -82.2% Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-07
Q3 2019 $577M $15M -$144M -90.6% Jun 1, 2019 Aug 31, 2019 10-K 2021-10-14
Q2 2019 $721M $156M +$47M +43.1% Mar 1, 2019 May 31, 2019 10-Q 2020-07-09
Q1 2019 $674M $226M -$277M -55.1% Dec 1, 2018 Feb 28, 2019 10-Q 2020-04-02
Q4 2018 $951M $180M -$47M -20.7% Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-08
Q3 2018 $998M $159M +$33M +26.2% Jun 1, 2018 Aug 31, 2018 10-K 2020-10-15
Q2 2018 $965M $109M -$59M -35.1% Mar 1, 2018 May 31, 2018 10-Q 2019-06-27
Q1 2018 $1.02B $503M +$257M +104% Dec 1, 2017 Feb 28, 2018 10-Q 2019-04-02
Q4 2017 $767M $227M +$7M +3.18% Sep 1, 2017 Nov 30, 2017 10-Q 2018-12-20
Q3 2017 $760M $126M -$81M -39.1% Jun 1, 2017 Aug 31, 2017 10-K 2019-10-28
Q2 2017 $841M $168M -$154M -47.8% Mar 1, 2017 May 31, 2017 10-Q 2018-06-28
Q1 2017 $995M $246M -$55M -18.3% Dec 1, 2016 Feb 28, 2017 10-Q 2018-03-28
Q4 2016 $1.05B $220M +$53M +31.7% Sep 1, 2016 Nov 30, 2016 10-Q 2018-01-04
Q3 2016 $997M $207M +$271M Jun 1, 2016 Aug 31, 2016 10-K 2018-10-11
Q2 2016 $726M $322M -$86M -21.1% Mar 1, 2016 May 31, 2016 10-Q 2017-06-29
Q1 2016 $812M $301M -$90M -23% Dec 1, 2015 Feb 29, 2016 10-Q 2017-04-05
Q4 2015 $902M $167M -$154M -48% Sep 1, 2015 Nov 30, 2015 10-Q 2017-01-05
Q3 2015 $1.06B -$64M Jun 1, 2015 Aug 31, 2015 10-K 2017-10-25
Q2 2015 $408M +$51M +14.3% Mar 1, 2015 May 31, 2015 10-Q 2016-07-06
Q1 2015 $391M $0 0% Dec 1, 2014 Feb 28, 2015 10-Q 2016-04-05
Q4 2014 $321M Sep 1, 2014 Nov 30, 2014 10-Q 2016-01-07
Q2 2014 $357M Mar 1, 2014 May 31, 2014 10-Q 2015-07-09
Q1 2014 $391M Dec 1, 2013 Feb 28, 2014 10-Q 2015-04-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.